1. Home
  2. NRSN vs NTZ Comparison

NRSN vs NTZ Comparison

Compare NRSN & NTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NeuroSense Therapeutics Ltd.

NRSN

NeuroSense Therapeutics Ltd.

HOLD

Current Price

$0.70

Market Cap

26.5M

Sector

Health Care

ML Signal

HOLD

Logo Natuzzi S.p.A.

NTZ

Natuzzi S.p.A.

HOLD

Current Price

$2.12

Market Cap

28.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
NRSN
NTZ
Founded
2017
1959
Country
Israel
Italy
Employees
16
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
28.0M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
NRSN
NTZ
Price
$0.70
$2.12
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$8.50
N/A
AVG Volume (30 Days)
131.3K
3.1K
Earning Date
03-31-2026
04-13-2023
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$583.67
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$2.10
52 Week High
$2.52
$3.95

Technical Indicators

Market Signals
Indicator
NRSN
NTZ
Relative Strength Index (RSI) 36.70 31.94
Support Level $0.67 N/A
Resistance Level $0.75 $3.19
Average True Range (ATR) 0.07 0.12
MACD -0.01 -0.02
Stochastic Oscillator 11.50 3.08

Price Performance

Historical Comparison
NRSN
NTZ

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases. These diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease, and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About NTZ Natuzzi S.p.A.

Natuzzi SpA is an Italian firm that designs, manufactures, and sells contemporary and traditional leather and fabric-upholstered furniture. Its product portfolio includes sofas, loveseats, armchairs, sectional furniture, motion furniture, sofa beds, living room furnishings, and accessories. The company markets its products under several brands such as Natuzzi Italia, Private Label, and Natuzzi Editions. The Group operates in two operating segments, the Natuzzi brand and Private label. The Natuzzi brand segment includes net sales from the Natuzzi Italia, Natuzzi Editions, and Divani&Divani by Natuzzi product lines. Geographically, it derives a majority of its revenue from the United States of America and also has an international presence in Italy, Spain, the UK, China, and Other countries.

Share on Social Networks: